A post hoc look at 31 GLP-1 users among 2,187 trial patients showed similar skin clearance and safety. Researchers note the small sample limits conclusions.
Recap by typeshit. Full story at Dermatology Advisor.
Experts say holding on to weight loss after quitting a GLP-1 is possible and walk through the habits they recommend for the transition.
The study of over 87,000 matched patients 65 and up also found 28% fewer liver decompensation events, but no drop in heart attack or stroke and more osteoporosis diagnoses.
18:05
Dr. Stirrett walks through three pointers for people on tirzepatide, framed as part of a broader GLP-1 guide. His advice, not a set protocol.
He walks through an Azoury et al study in the October 2026 Plastic and Reconstructive Surgery that uses global health network data to compare the two weight loss routes.
The Long Covid account is hosting a live discussion at 6pm UK on whether GLP-1 drugs might help with Long Covid symptoms.
Bahrain's health regulator has cleared the pill form of semaglutide, following the UAE as the second Gulf state to make it available.
Loading…